5G NTN Market was Dominated by Solutions Category

The size of the 5G NTN market was USD 3,495 million in 2022, and will reach USD 25,184 million by 2030, progressing at a...
HomeHealth NewsBreast Biopsy Devices Market Latest Trend, Advancement, Growth and Business Opportunities

Breast Biopsy Devices Market Latest Trend, Advancement, Growth and Business Opportunities

How will High Breast Cancer Burden Fuel Breast Biopsy Device Demand? 

This life-threatening disease is caused due to abnormal cell growth, which eventually forms a lump or mass in the breasts. Cells may spread or metastasize through the breast to lymph nodes or other body parts.  

In contemporary times, the liquid biopsy technique is being increasingly used to investigate breast cancer, as liquid biopsy or the analysis of circulating tumor deoxyribonucleic acid (ctDNA) is used to study the genetic profile related to cancer and track the therapeutic response of affected people.  

Moreover, the surging population of geriatric women will also grow at an enormous requirement for breast biopsy devices in the upcoming years, as they are highly vulnerable to this chronic disease. The United Nations Department of Economic and Social Affairs (UNDESA) states that women account for a large portion of the elderly population. 

To download free sample copy of this report@ https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market/report-sample

Biopsy tables, biopsy needles/guns, biopsy wires, and guidance systems are the different types of breast biopsy devices being used to detect breast cancer. In the last few years, guidance systems were adopted in the highest quantity as they have the options for stereotactic breast biopsy and tomosynthesis. In the preceding years, diagnostic centers emerged as the larger users of these devices due to the mounting research and development (R&D) expenditure and booming healthcare sector. In the coming years, hospitals will also deploy a large number of devices, owing to the surging patient footfall in these facilities.  

Medical professionals at diagnostic centers and hospitals rely on vacuum-assisted, fine-needle aspiration, core-needle, and surgical procedures to identify tumors in breasts. In the upcoming years, end users will increase their reliance on the vacuum-assisted procedure as it enables easy sample extraction from the suspected area by accurately identifying the area experiencing abnormal growth. The end users carry out these procedures with the assistance of computed tomography (CT), ultrasound, mammography-guided stereotactic, and magnetic resonance imaging (MRI) modalities. 

Geographically, the North American region dominated the breast biopsy devices market in the recent past. In this region, the U.S. is a prominent user of such devices due to the increasing incidence of breast cancer, growing geriatric population, mounting healthcare spending, and expanding healthcare industry in the country. Furthermore, the Asia-Pacific (APAC) region will also deploy a significant volume of breast biopsy devices, on account of the booming elderly population, rising healthcare expenditure, soaring per capita income, and mounting public awareness about breast cancer. 

Thus, the surging prevalence of breast cancer and mushrooming population of geriatric women will create a huge requirement for breast biopsy devices in the foreseeable future. 

SOURCE: P&S Intelligence